Axios hosted a live, virtual event on the impact of the coronavirus on biomedical innovations and the challenges of making treatments like gene therapy affordable and accessible, featuring the FDA's Director of the Center for Biologics Evaluation and Research Dr. Peter Marks, Rep. Scott Peters (D-Calif.) and Real Endpoints EVP & Chief Clinical Officer Dr. Jane Barlow.
